"Indianapolis dermatology practice offering skin cancer and laser/cosmetic treatments, body sculpting, & #LASSISKIN aesthetics services under the medical direction of board-certified dermatologist and dermatologic surgeon C. William Hanke, MD, FACP."

During the past decade, Laser & Skin Surgery Center of Indiana conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 12 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Laser & Skin Surgery Center of Indiana" #1 sponsor was "LEO Pharma" with 4 trials, followed by "Allergan" with 2 trials sponsored, "Biofrontera Bioscience GmbH" with 2 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Merz Pharmaceuticals GmbH" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Laser & Skin Surgery Center of Indiana" #1 collaborator was "Athenex, Inc." with 1 trials as a collaborator, "Neothetics, Inc" with 1 trials as a collaborator and "TKL Research, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Laser & Skin Surgery Center of Indiana" are "Actinic Keratosis" (8 trials), "Basal Cell Carcinoma" (3 trials), "Basal Cell Nevus Syndrome" (2 trials), "Glabellar Lines" (2 trials) and "Central Abdominal Bulging" (1 trials). Many other conditions were trialed in "Laser & Skin Surgery Center of Indiana" in a lesser frequency.

Most popular intervention types in "Laser & Skin Surgery Center of Indiana" are "Drug" (18 trials), "Device" (3 trials), "Other" (3 trials), "Combination Product" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Patidegib Topical Gel, 2%" (2 trials), "Vehicle" (2 trials), "Vehicle gel" (2 trials) and "Vismodegib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Laser & Skin Surgery Center of Indiana" are 22 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Laser & Skin Surgery Center of Indiana". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Laser & Skin Surgery Center of Indiana, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Laser & Skin Surgery Center of Indiana, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".